18 December 2014
Stable long-term investment in medical research is vital for the development of new treatments and also generates economic benefits for the UK.
- Long-term government investment in research through the dual support system is needed to underpin the UK’s vibrant science base. It allows scientists to access a diverse mix of funding and respond to new challenges and opportunities.
- The Charity Research Support Fund (CRSF), distributed by the Higher Education Funding Council for England (HEFCE), supports world-class universities and enables public donations to be spent directly on research. The fund should be increased to reflect greater charity investment.
- Investment in research by the Medical Research Council (MRC) must be protected and increased to provide a strong foundation of knowledge and expertise on which charities can build.
Quality and standards
- Where medical research charities fund in collaboration with others the resulting research is often exceptionally high impact, involving international co-authors.
- Charities want to maximise the impact of every pound they spend. Many use tools like Researchfish to track outcomes and inform future strategy.
- Our Industry-Charity Advisory Group is identifying ways to build more collaborations and attract further investment to speed up the development of new treatments for patients.
Data and impact
- Medical research is the UK’s favourite charitable cause, with 7.6 million people donating in a typical month.
- AMRC members have together invested more than £1 billion into UK medical research in each of the past seven years. The UK is unique for the size of its charity research-funding sector.
- Our case studies and data demonstrate the value of charity investment in UK research.
- Each pound invested in medical research by the taxpayer and charities returns around 40p to the UK every year in perpetuity.